GBA1 and Parkinson disease: These GBA1 mutations also lead to loss of GCase activity and accumulation of its lipid substrates in the lysosome, consequently impairing the lysosomal function (Leyns et al., 2023), revealing that there is a connection between ER and lipid dyshomeostasis in PD.